Eurofins LifeCodexx GmbH

Eurofins LifeCodexx GmbH is a German biotechnology and clinical diagnostics company specializing in non-invasive prenatal testing (NIPT) and advanced genetic diagnostics. Founded in 2010 and based in Planegg near Munich, the company pioneered European NIPT diagnostics with the launch of the PraenaTest in 2012. The proprietary PraenaTest analyzes cell-free fetal DNA from maternal blood samples to detect chromosomal abnormalities including Trisomy 21, Trisomy 18, Trisomy 13, sex chromosome aneuploidies, rare autosomal aneuploidies, and microdeletions such as 22q11.2. As part of Eurofins Scientific's Clinical Diagnostics division, Eurofins LifeCodexx serves expectant mothers, gynecological practices, clinics, and medical specialists across Europe, the Middle East, and Asia. The company offers accredited laboratory testing services, rapid result turnaround times, and comprehensive bioinformatic data analysis. Healthcare providers can utilize their online ordering service for prenatal diagnostic kits and sample analysis. Eurofins LifeCodexx continuously advances molecular genetic assays and next-generation sequencing solutions to improve prenatal care and early genetic risk assessment.